SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 209.02+3.2%Nov 10 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (21066)5/19/1998 5:51:00 PM
From: Andrew H  Read Replies (1) of 32384
 
Great news! Extremely non-toxic, even at higher dose levels and does not induce its own metabolism. Now if it is only effective!!

>>With limited information from the higher dose levels, Memorial Sloan- Kettering investigators observed no dose-limiting toxicities and observed only minor adverse events in LGD1550 treated patients. The maximum tolerated dose has not been determined. Unlike all-trans retinoic acid, a retinoid approved for the treatment of acute promyelocytic leukemia, LGD1550 does not appear to induce its own metabolism over the dose range tested since blood levels are maintained with continued therapy. <<

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext